Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination

10.3390/vaccines9090974

Saved in:

Bibliographic Details
Main Authors:	Lim, Xin Rong, Leung, Bernard Pui, Ng, Carol Yee Leng, Tan, Justina Wei Lynn, Chan, Grace Yin Lai, Loh, Chien Mei, Tan, Gwendolyn Li Xuan, Goh, Valerie Hui Hian, Wong, Lok To, Chua, Chong Rui, Tan, Sze Chin, Lee, Samuel Shang Ming, Howe, Hwee Siew, Thong, Bernard Yu Hor, Leong, Khai Pang
Other Authors:	PHYSIOLOGY
Format:	Article
Language:	English
Published:	MDPI 2021
Subjects:	Science & Technology Life Sciences & Biomedicine Immunology Medicine, Research & Experimental Research & Experimental Medicine COVID-19 vaccine anaphylaxis antibodies cytokines
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/209061
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Similar Items

Anaphylatoxin Complement 5a in Pfizer BNT162b2-Induced Immediate-Type Vaccine Hypersensitivity Reactions
by: Lim, Xin Rong, et al.
Published: (2023)

Ventricular tachycardia from myocarditis following COVID-19 vaccination with tozinameran (BNT162b2, Pfizer-BioNTech)
by: Lin, Weiqin, et al.
Published: (2022)

Toxic epidermal necrolysis after first dose of Pfizer-BioNTech (BNT162b2) vaccination with pharmacogenomic testing
by: Siripipattanamongkol N.
Published: (2023)

Human Milk Antibodies after BNT162b2 Vaccination Exhibit Reduced Binding against SARS-CoV-2 Variants of Concern
by: Low, Jia Ming, et al.
Published: (2023)

Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age
by: Tan, Sharon H. X., et al.
Published: (2023)

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
by: Rebecca P. Payne, et al.
Published: (2022)

Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
by: Mansanguan S.
Published: (2023)

BNT162b2 vaccination induces SARS-CoV-2 specific antibody secretion into human milk with minimal transfer of vaccine mRNA
by: Low, Jia Ming, et al.
Published: (2023)

Polyneuritis Cranialis Associated with BNT162b2 mRNA COVID-19 Vaccine in a Healthy Adolescent
by: Pimchanok Kulsirichawaroj, et al.
Published: (2022)

Polyneuritis Cranialis Associated with BNT162b2 mRNA COVID-19 Vaccine in a Healthy Adolescent
by: Kulsirichawaroj P.
Published: (2023)

Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
by: Renia, Laurent, et al.
Published: (2023)

Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
by: Renia, Laurent, et al.
Published: (2022)

Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases
by: Napaporn Chantasrisawad, et al.
Published: (2022)

Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases
by: Chantasrisawad N.
Published: (2023)

Codominant IgG and IgA expression with minimal vaccine mRNA in milk of BNT162b2 vaccinees
by: Low, Jia Ming, et al.
Published: (2021)

Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivor
by: Chia, Wan Ni, et al.
Published: (2023)

Clinical Course, Immunogenicity, and Efficacy of BNT162b2 mRNA Vaccination Against SARS-CoV-2 Infection in Liver Transplant Recipients
by: Tan, Eunice X, et al.
Published: (2023)

Clinical course, immunogenicity, and efficacy of BNT162b2 mRNA vaccination against SARS-CoV-2 infection in liver transplant recipients
by: Tan, Eunice X., et al.
Published: (2024)

Human Milk Antibodies Elicited by BNT162b2 Vaccination have reduced activity against SARS-CoV-2 Variants of Concern
by: Low, Jia Ming, et al.
Published: (2023)

BNT162b2 vaccine protection against omicron and effect of previous infection variant and vaccination sequence among children and adolescents in Singapore: a population-based cohort study.
by: Yung, Chee Fu, et al.
Published: (2023)

The rapid progress in COVID vaccine development and implementation
by: Barrett, Alan DT, et al.
Published: (2023)

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults
by: Suvimol Niyomnaitham, et al.
Published: (2022)

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults
by: Niyomnaitham S.
Published: (2023)

BNT162b2 mRNA SARS-CoV-2 vaccination does not cause upregulation of endothelial activation markers or hypercoagulability: A prospective, single-arm, longitudinal study
by: Lim, Xin Rong, et al.
Published: (2023)

Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants
by: Niyomnaitham S.
Published: (2023)

Resistance of SARS-CoV-2 Delta variant to neutralization by BNT162b2-elicited antibodies in Asians
by: Wang, Bei, et al.
Published: (2022)

BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study
by: Yung, Chee Fu, et al.
Published: (2024)

Anaphylaxis in the Asia Pacific
by: de, Bruyne J.A., et al.
Published: (2013)

Decreased memory B cell frequencies in COVID-19 delta variant vaccine breakthrough infection
by: Tay, Matthew Zirui, et al.
Published: (2022)

Robust sars?cov?2 antibody responses in asian covid?naïve subjects 180 days after two doses of bnt162b2 mrna covid?19 vaccine
by: Lau, Chin-Shern, et al.
Published: (2022)

Management of anaphylaxis due to COVID-19 vaccines in the elderly
by: Bousquet, J, et al.
Published: (2022)

Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBB
by: Chang, Zi Wei, et al.
Published: (2023)

Expression Pattern and Diagnostic Utility of BCL11B in T and NK-cell Neoplasms
by: Fang, Hong, et al.
Published: (2022)

Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
by: Goh, Yun Shan, et al.
Published: (2023)

Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
by: Goh, Yun Shan, et al.
Published: (2023)

Safety and immunogenicity of intradermal administration of fractional dose CoronaVac<sup>®</sup>, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination
by: Chatsiricharoenkul S.
Published: (2023)

Incidence and characterization of intestinal helminths among dogs in an animal shelter in Bacoor, Cavite
by: Cuizon, Nikka Ileana C.
Published: (2014)

Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5–11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial
by: Wittawatmongkol O.
Published: (2023)

Recurrent Respiratory Papillomatosis (RRP)-Meta-analyses on the use of the HPV vaccine as adjuvant therapy
by: Goon, Peter, et al.
Published: (2023)

Food-dependent exercise-induced anaphylaxis - A review of 5 cases
by: Teo, S.-L., et al.
Published: (2011)